Free Trial
→ Elon’s Secret Social Security Bombshell (From Banyan Hill Publishing) (Ad) Free BTAI Stock Alerts

BioXcel Therapeutics (BTAI) Short Interest Ratio & Short Volume

BioXcel Therapeutics logo
$3.32 +0.35 (+11.78%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$3.19 -0.13 (-3.83%)
As of 05:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

BioXcel Therapeutics Short Interest Data

BioXcel Therapeutics (BTAI) has a short interest of 352,200 shares, representing 6.37% of the float (the number of shares available for trading by the public). This marks a 4.70% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 11.93 million shares to cover all short positions.

Current Short Interest
352,200 shares
Previous Short Interest
336,400 shares
Change Vs. Previous Month
+4.70%
Dollar Volume Sold Short
$669.18 thousand
Short Interest Ratio
1.1 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
6,060,000 shares
Float Size
5,530,000 shares
Short Percent of Float
6.37%
Today's Trading Volume
48,741,197 shares
Average Trading Volume
11,928,798 shares
Today's Volume Vs. Average
409%
Short Selling BioXcel Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioXcel Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BTAI Short Interest Over Time

BTAI Days to Cover Over Time

BTAI Percentage of Float Shorted Over Time

BioXcel Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/2025352,200 shares $669.18 thousand +4.7%6.4%1.1 $1.90
6/30/2025336,400 shares $608.88 thousand +5.9%6.1%1.3 $1.81
6/15/2025317,600 shares $495.46 thousand -38.4%5.7%1.3 $1.56
5/31/2025515,700 shares $608.53 thousand +285.4%9.3%1.5 $1.18
5/15/2025133,800 shares $195.35 thousand +52.1%2.4%0 $1.46
4/30/202588,000 shares $162.80 thousand +18.4%1.9%0 $1.85
4/15/202574,300 shares $135.23 thousand -66.6%1.6%0 $1.82
3/31/2025222,700 shares $452.08 thousand +0.6%4.9%0.1 $2.03
3/15/2025221,300 shares $471.37 thousand -33.0%8.1%0.1 $2.13
2/28/2025330,500 shares $713.88 thousand +16.2%12.1%0.1 $2.16
2/15/2025284,500 shares $657.20 thousand +13.5%11.0%2 $2.31
1/31/2025250,700 shares $1.31 million -84.3%9.7%2.1 $5.22
1/15/20251,600,000 shares $554.40 thousand +98.1%N/A1.1 $0.35
12/31/2024807,700 shares $302.00 thousand -23.1%N/A1 $0.37
12/15/20241,050,000 shares $432.71 thousand +16.8%N/A1.7 $0.41
11/30/2024898,700 shares $367.30 thousand +44.0%N/A1.4 $0.41
11/15/2024624,100 shares $354.68 thousand +79.8%N/A1.2 $0.57
10/31/2024347,100 shares $231.45 thousand -39.8%N/A0.7 $0.67
10/15/2024576,400 shares $327.91 thousand +11.6%N/A1.2 $0.57
9/30/2024516,400 shares $315.00 thousand -26.0%N/A0.9 $0.61
9/15/2024697,600 shares $474.37 thousand +2.5%N/A1.1 $0.68
8/31/2024680,500 shares $418.51 thousand -6.9%N/A1.2 $0.62
8/15/2024731,200 shares $497.22 thousand -9.4%N/A1.2 $0.68
7/31/2024807,300 shares $904.18 thousand +28.9%N/A1.2 $1.12
7/15/2024626,100 shares $763.84 thousand -61.4%N/A1 $1.22
6/30/20241,620,000 shares $2.07 million +8.7%N/A2.8 $1.28
6/15/20241,490,000 shares $2.04 million +0.7%N/A2.9 $1.37
5/31/20241,480,000 shares $2.68 million -9.2%N/A2.6 $1.81
5/15/20241,630,000 shares $3.36 million +8.7%N/A2.8 $2.06
4/30/20241,500,000 shares $3.78 million -28.2%N/A1 $2.52
4/15/20242,090,000 shares $5.75 million -16.1%N/A1.4 $2.75
3/31/20242,490,000 shares $7.02 million -20.7%10.5%1.7 $2.82
3/15/20243,140,000 shares $8.42 million -20.9%14.6%2.1 $2.68
2/29/20243,970,000 shares $12.62 million -46.8%18.7%2.6 $3.18
2/15/20247,460,000 shares $26.78 million +203.3%35.2%4.9 $3.59
1/31/20242,460,000 shares $7.92 million -17.5%11.9%2.1 $3.22
1/15/20242,980,000 shares $7.84 million +0.3%14.4%1.1 $2.63
12/31/20232,970,000 shares $8.76 million +3.5%14.7%1 $2.95
12/15/20232,870,000 shares $9.30 million -16.6%14.2%0.9 $3.24
11/30/20233,440,000 shares $13.07 million -32.3%17.0%1.1 $3.80
One stock to replace Nvidia (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
11/15/20235,080,000 shares $22.35 million -12.6%25.1%1.6 $4.40
10/31/20235,810,000 shares $23.33 million +16.9%28.8%1.9 $4.02
10/15/20234,970,000 shares $15.56 million +38.8%24.6%3.6 $3.13
9/30/20233,580,000 shares $9.06 million -24.6%17.7%2.4 $2.53
9/15/20234,750,000 shares $15.87 million +8.0%23.5%1.6 $3.34
8/31/20234,400,000 shares $16.63 million -34.8%21.8%1.5 $3.78
8/15/20236,750,000 shares $27.95 million -4.1%33.5%2.3 $4.14
7/31/20237,040,000 shares $64.35 million -18.8%35.0%2.7 $9.14
7/15/20238,670,000 shares $89.30 million +69.0%43.1%3.5 $10.30
6/30/20235,130,000 shares $34.17 million +12.3%25.5%2.2 $6.66
6/15/20234,570,000 shares $98.26 million +22.9%22.7%8.3 $21.50
5/31/20233,720,000 shares $66.74 million +11.0%18.5%6.2 $17.94
5/15/20233,350,000 shares $91.22 million -5.4%16.7%6.5 $27.23
4/30/20233,540,000 shares $72.99 million -5.1%17.7%6.9 $20.62
4/15/20233,730,000 shares $69.90 million +3.6%18.6%7.4 $18.74
3/31/20233,600,000 shares $67.18 million +21.2%18.3%7.2 $18.66
3/15/20232,970,000 shares $58.21 million +5.7%15.1%6.3 $19.60
2/28/20232,810,000 shares $89.70 million +8.9%14.7%8 $31.92
2/15/20232,580,000 shares $84.29 million +5.3%13.5%7.6 $32.67
1/31/20232,450,000 shares $69.87 million +5.6%12.9%7.4 $28.52
1/15/20232,320,000 shares $67.14 million -3.3%12.2%8.1 $28.94
12/30/20222,400,000 shares $51.55 million +10.1%12.6%9.4 $21.48
12/15/20222,180,000 shares $44.04 million -4.4%11.5%9 $20.20
11/30/20222,280,000 shares $37.78 million -3.4%12.0%10.2 $16.57
11/15/20222,360,000 shares $38.00 million -6.7%12.4%10.9 $16.10
10/31/20222,530,000 shares $31.85 million -4.2%13.3%11.7 $12.59
10/15/20222,640,000 shares $27.06 million -5.7%13.9%11.1 $10.25
9/30/20222,800,000 shares $33.10 million -2.1%14.7%10.4 $11.82
9/15/20222,860,000 shares $37.95 million -2.4%15.0%8.5 $13.27
8/31/20222,930,000 shares $40.08 million -0.3%15.4%6.9 $13.68
8/15/20222,940,000 shares $44.86 million +7.7%15.5%6.1 $15.26
7/31/20222,730,000 shares $42.15 million -5.5%14.4%5 $15.44
7/15/20222,890,000 shares $48.70 million -19.7%15.2%5 $16.85
6/30/20223,600,000 shares $47.52 million -9.3%19.0%4 $13.20
6/15/20223,970,000 shares $39.14 million -1.2%20.9%4.4 $9.86
5/31/20224,020,000 shares $47.03 million -2.9%21.2%4.8 $11.70
5/15/20224,140,000 shares $48.60 million +5.3%21.8%5.2 $11.74
4/30/20223,930,000 shares $51.52 million -3.0%20.7%5.3 $13.11
4/15/20224,050,000 shares $63.10 million +97.6%21.4%5.7 $15.58
3/31/20222,050,000 shares $42.87 million +9.0%10.8%3.3 $20.91
3/15/20221,880,000 shares $28.31 million +0.5%9.9%6.1 $15.06
2/28/20221,870,000 shares $34.24 million +10.7%9.9%6.5 $18.31
2/15/20221,690,000 shares $31.38 million -5.1%8.9%5.4 $18.57
1/31/20221,780,000 shares $30.08 million -0.6%9.4%5.5 $16.90
1/15/20221,790,000 shares $34.91 million +3.5%9.4%5.9 $19.50
12/31/20211,730,000 shares $35.17 million -11.7%9.1%5.7 $20.33
12/15/20211,960,000 shares $42.59 million -1.0%10.3%6.7 $21.73
11/30/20211,980,000 shares $45.40 million +10.6%10.4%6.9 $22.93
11/15/20211,790,000 shares $48.71 million -4.3%9.4%6.6 $27.21
10/29/20211,870,000 shares $54.49 million +8.1%9.9%7.5 $29.14
One stock to replace Nvidia (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
10/15/20211,730,000 shares $46.87 million -6.0%9.1%6.7 $27.09
9/30/20211,840,000 shares $55.84 million -3.2%9.7%6.9 $30.35
9/15/20211,900,000 shares $56.51 million -6.9%10.0%5.4 $29.74
8/31/20212,040,000 shares $60.08 million -8.1%10.8%5.4 $29.45
8/13/20212,220,000 shares $54.59 million -5.9%11.8%5.9 $24.59
7/30/20212,360,000 shares $60.39 million -9.9%12.6%6.1 $25.59
7/15/20212,620,000 shares $70.11 million -11.8%14.0%6.8 $26.76
6/30/20212,970,000 shares $86.31 million +2.1%16.9%7.7 $29.06
6/15/20212,910,000 shares $108.60 million -5.5%19.2%7.8 $37.32
5/28/20213,080,000 shares $101.73 million -3.1%20.3%7.8 $33.03
5/14/20213,180,000 shares $96.67 million -5.6%21.0%7.3 $30.40
4/30/20213,370,000 shares $116.27 million -7.7%22.3%7.1 $34.50
4/15/20213,650,000 shares $127.57 million +9.0%N/A7 $34.95
3/31/20213,350,000 shares $137.69 million -9.7%21.4%6.1 $41.10
3/15/20213,710,000 shares $174.33 million +2.8%23.8%6.5 $46.99
2/26/20213,610,000 shares $199.09 million +1.1%23.4%6.7 $55.15
2/12/20213,570,000 shares $230.62 million +5.6%23.1%6.8 $64.60
1/29/20213,380,000 shares $156.33 million -7.9%23.0%6.6 $46.25
1/15/20213,670,000 shares $198.55 million +10.2%25.0%7.7 $54.10
12/31/20203,330,000 shares $163.90 million +4.4%22.7%6.9 $49.22
12/15/20203,190,000 shares $147.89 million -2.5%21.8%7.2 $46.36
11/30/20203,270,000 shares $145.81 million +10.9%22.3%7.2 $44.59
11/15/20202,950,000 shares $160.13 million +4.2%20.1%6.2 $54.28
10/30/20202,830,000 shares $133.15 million +22.0%22.4%5.2 $47.05
10/15/20202,320,000 shares $120.41 million -13.8%18.3%3.5 $51.90
9/30/20202,690,000 shares $116.64 million +17.0%21.3%3.9 $43.36
9/15/20202,300,000 shares $111.09 million +6.5%18.2%3.3 $48.30
8/31/20202,160,000 shares $88.02 million -10.4%17.1%3.1 $40.75
8/14/20202,410,000 shares $90.42 million -14.2%20.7%3.5 $37.52

BTAI Short Interest - Frequently Asked Questions

What is BioXcel Therapeutics' current short interest?

Short interest is the volume of BioXcel Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 352,200 shares of BTAI short. 6.37% of BioXcel Therapeutics' shares are currently sold short. Learn More on BioXcel Therapeutics' current short interest.

What is a good short interest ratio for BioXcel Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BTAI shares currently have a short interest ratio of 1.0. Learn More on BioXcel Therapeutics's short interest ratio.

What is a good short interest percentage for BioXcel Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.37% of BioXcel Therapeutics' floating shares are currently sold short.

Is BioXcel Therapeutics' short interest increasing or decreasing?

BioXcel Therapeutics saw a increase in short interest in July. As of July 15th, there was short interest totaling 352,200 shares, an increase of 4.7% from the previous total of 336,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BioXcel Therapeutics' float size?

BioXcel Therapeutics currently has issued a total of 6,060,000 shares. Some of BioXcel Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioXcel Therapeutics currently has a public float of 5,530,000 shares.

How does BioXcel Therapeutics' short interest compare to its competitors?

6.37% of BioXcel Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioXcel Therapeutics: Mersana Therapeutics, Inc. (158.72%), Akari Therapeutics PLC (0.13%), Estrella Immunopharma, Inc. (1.94%), Iterum Therapeutics PLC (4.46%), Dyadic International Inc. (0.52%), Clearside Biomedical, Inc. (0.21%), Kezar Life Sciences, Inc. (5.98%), Clene Inc. (4.02%), Generation Bio Co. (1.78%), FibroGen, Inc (4.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short BioXcel Therapeutics stock?

Short selling BTAI is an investing strategy that aims to generate trading profit from BioXcel Therapeutics as its price is falling. BTAI shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioXcel Therapeutics?

A short squeeze for BioXcel Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BTAI, which in turn drives the price of the stock up even further.

How often is BioXcel Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTAI, twice per month. The most recent reporting period available is July, 15 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:BTAI) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
[Shocking New Report] U.S. Dollar To Crash?
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
Goldco Precious Metals | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...
American Alternative | Sponsored